Indian shares opened little changed after the Federal Reserve held rates steady, amidst geopolitical risks pushing Brent crude lower. Meanwhile, Sun Pharma gained approval to manufacture semaglutide i
Sun Pharmaceutical Industries announced the acquisition of 100% of Innovcare Lifesciences for approximately $28.73 million (2.71 billion rupees).
Sun Pharmaceutical Industries agreed to acquire Organon for $11.75 billion, gaining access to its biosimilars portfolio and becoming a top-three global women's health company.
India's Sun Pharmaceutical Industries agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion. The transaction grants Sun Pharma full ownership of the
ChemBrief